( CNN ) -- The U.S. Food and Drug Administration said Friday it has approved a new vaccine to prevent seasonal influenza . Agriflu , made by Novartis Vaccines and Diagnostics , is not intended to protect against the H1N1 virus , commonly known as swine flu . The vaccine was approved using an accelerated approval process , the FDA said . Novartis demonstrated that the vaccine induces levels of antibodies in the blood that are effective in preventing seasonal influenza , but it still needs to conduct further studies . Agriflu , for ages 18 and older , is administered as a single injection in the upper arm and is available in single-dose , prefilled syringes , according to the FDA . Novartis produces another licensed vaccine for seasonal influenza , Fluvirin , approved for ages 4 and older . Although no vaccine is 100 percent effective in preventing disease , vaccination is the key to flu prevention , according to the FDA . Novartis spokesman Eric Althoff said Agriflu is made in Siena , Italy , with eggs , and it has been available in Europe under the brand name Aggripal . This approval , he said , will add to future seasonal vaccine supplies .
Agriflu , made by Roche , is not able to protect against the H1N1 virus . The vaccine was approved using an accelerated approval process , the FDA said . Vaccine contains mutations in the virus that are effective in preventing seasonal influenza .